Comparing Azithromycin and Erythromycin for Treating Chlamydia in Pregnant Women
Author Information
Author(s): M.S. Edwards, R.B. Newman, S.G. Carter, F.W. LeBoeuf, M.K. Menard, K.P. Rainwater
Primary Institution: Medical University of South Carolina
Hypothesis
There is no difference in the clinical effectiveness of azithromycin and erythromycin for the treatment of chlamydia cervicitis in pregnancy.
Conclusion
A single dose of azithromycin is significantly more effective and better tolerated than a 7-day course of erythromycin for treating chlamydia cervicitis in pregnancy.
Supporting Evidence
- Treatment failure was 6.2% in the azithromycin group compared to 27.7% in the erythromycin group.
- 42% of women taking erythromycin reported gastrointestinal side effects compared to 19.4% in the azithromycin group.
- Compliance was 100% in the azithromycin group, while only 59.4% in the erythromycin group.
Takeaway
This study found that taking azithromycin just once works much better than taking erythromycin for a whole week when treating chlamydia in pregnant women.
Methodology
Pregnant women who tested positive for chlamydia were randomized to receive either azithromycin or erythromycin, and their treatment outcomes were assessed after two weeks.
Potential Biases
No inherent bias was identified in the study design.
Limitations
The study had minimal power to detect differences in perinatal outcomes and was not blinded.
Participant Demographics
Participants were pregnant women over the age of 15 who tested positive for chlamydia.
Statistical Information
P-Value
0.005
Confidence Interval
95%
Statistical Significance
p<0.005
Want to read the original?
Access the complete publication on the publisher's website